GlobeNewswire 4/9/2025 Augustine Therapeutics appoints Industry Veteran Pascale Witz as Chair of its Board of Directors

GlobeNewswire 4/7/2025 Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL

GlobeNewswire 3/27/2025 USHBC Congratulates Cristina Antelo on Ferox Strategies’ Expansion

GlobeNewswire 3/18/2025 Leading Academic and Manufacturing Organizations Join Ori Biotech’s Preferred Partner Network to Acc...

TeleTrader 2/26/2025 Europe closes sharply up on good financial reports

TeleTrader 2/26/2025 DAX surges over 360 pts on strong earnings reports

TeleTrader 2/14/2025 Europe closes mostly lower amid Munich conference

TeleTrader 2/10/2025 European markets open higher despite US tariff concerns

TeleTrader 11/21/2024 Europe opens mixed amid data, central bankers remarks

TeleTrader 11/4/2024 Europe mostly down at close as US election draws near

TeleTrader 10/28/2024 Europe closes higher with earnings in focus

GlobeNewswire 8/13/2024 CytoSorbents Reports Second Quarter 2024 Financial and Operational Results

GlobeNewswire 7/10/2024 Unicycive Therapeutics Announces Initial Positive Patient Satisfaction Findings from Pivotal Clinica...

GlobeNewswire 6/10/2024 SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company

GlobeNewswire 5/16/2024 American Oncology Network Appoints New Board Member

GlobeNewswire 5/10/2024 Humacyte First Quarter 2024 Financial Results and Business Update

GlobeNewswire 5/7/2024 OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

GlobeNewswire 5/7/2024 Memo Therapeutics increases Series C financing to CHF 45 million

GlobeNewswire 4/24/2024 Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...

GlobeNewswire 4/23/2024 Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...

GlobeNewswire 3/14/2024 CytoSorbents Reports Fourth Quarter and Full Year 2023 Results

GlobeNewswire 3/4/2024 Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire 2/23/2024 Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...